"Adama will not need to be sold"
"Adama will not need to be sold. There will be some remedies in both the U.S. and the EU but I can't speak to any details," Erik Fyrwald told Reuters on the sidelines of the World Economic Forum in Davos.
Unveiling details about Syngenta's future role within ChemChina for the first time, Fyrwald also said Israel-based Adama, a maker of generic versions of pesticides without patent protection, would not be folded into Syngenta, allowing the Swiss group to focus on biotech research in China and elsewhere.
Read more at Reuters